Dr. Agarwal’s Health Care reported strong unaudited consolidated financial results. Total income surged by 20.2% YoY to ₹1,007 Crores in H1 FY26. EBITDA grew by 24.9% YoY to ₹285 Crores, and PAT rose by 88.4% YoY to ₹75 Crores. The company’s network includes 258 facilities across 10 countries. In Q2 FY26, revenue from operations reached ₹499 Cr, a 19.7% YoY increase.
H1 FY26 Financial Highlights
Dr. Agarwal’s Health Care Limited reported impressive financial performance for the first half of fiscal year 2026:
- Total Income: ₹1,007 Crores, up 20.2% YoY
- EBITDA: ₹285 Crores, a 24.9% YoY increase
- Profit After Tax (PAT): ₹75 Crores, soaring 88.4% YoY
Q2 FY26 Performance
Key metrics for the second quarter of fiscal year 2026 (July-September):
- Revenue from Operations: ₹499 Cr, reflecting a 19.7% YoY growth
- India Revenue: ₹445 Cr, with a 19.8% YoY increase
- Mature Facilities Revenue: ₹371 Cr, up by 12.7% YoY
- EBITDA: ₹144 Cr, a 21.2% YoY rise with 28.4% margins
- Profit After Tax: ₹36 Cr, a substantial 71.0% YoY increase, resulting in 7.2% margins
Operational Milestones
As of September 30, 2025, the company’s network included 258 facilities, with 11 new centers added during the quarter. The company performed 78,399 surgeries in Q2 FY26, marking a 13.3% YoY growth. Sale of Services contributed 78.1% and Sale of Products 21.7% to revenue from operations.
Strategic Outlook
The company expanded to 258 eye care facilities, serving over 1.4 million patients and performing over 157,000 surgeries during the first half. Recent entry into the Delhi market has shown encouraging results, with plans to accelerate expansion across North India. The company anticipates continued growth, driven by demand and expansion initiatives.
Source: BSE
